BrainsWay Announces Ongoing Growth of Deep TMS™ in South Korea

Friday, December 08, 2023

BrainsWay, a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, has announced the expanded availability of its Deep Transcranial Magnetic Stimulation (Deep TMS™) technology in South Korea. With growing momentum over recent years, the company foresees that recent sales will contribute to a total of over 20 installed Deep TMS systems in the country. 

The broader access to Deep TMS, recognized for its robust scientific foundation and evidence, aligns with BrainsWay's overarching mission to enhance health and positively impact lives globally.

Delivered through a patented coil design housed within a comfortable helmet for patients and providers, Deep TMS emits a magnetic field targeted at specific structures in the brain, effectively stimulating crucial neural networks. BrainsWay's unique therapeutic solution is currently approved in South Korea for treating major depressive disorder.